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Complex stability and dynamic 
subunit interchange modulates the 
disparate activities of the yeast 
moonlighting proteins Hal3 and 
Vhs3
J. Albert Abrie1, Cristina Molero2, Joaquín Ariño2 & Erick Strauss1
Saccharomyces cerevisiae Hal3 and Vhs3 are moonlighting proteins, acting both as inhibitors of 
the serine/threonine protein phosphatase Ppz1 and as subunits (together with Cab3) of the unique 
heterotrimeric phosphopantothenoylcysteine decarboxylase (PPCDC) enzyme of Hemiascomycetous 
yeast. Both these roles are essential: PPCDC catalyses the third step of coenzyme A biosynthesis, 
while Ppz1 inhibition is required for regulation of monovalent cation homeostasis. However, the 
mechanisms by which these proteins’ disparate activities are regulated are not well understood. 
The PPCDC domains (PDs) of Hal3, Vhs3 and Cab3 constitute the minimum requirement for these 
proteins to show both PPCDC activity and, in the case of Hal3 and Vhs3, to bind to Ppz1. Using 
these PD proteins as a model system to study the possibility of dynamic interchange between these 
roles, we provide evidence that Hal3 binds Ppz1 as a monomer (1:1 stoichiometry), requiring it to de-
oligomerize from its usual homo- and heterotrimeric states (the latter having PPCDC activity). This 
de-oligomerization is made possible by structural features that set Hal3 apart from Vhs3, increasing 
its ability to undergo monomer exchange. These findings suggest that oligomer interchange may 
be a significant factor in the functional regulation of these proteins and their various unrelated 
(moonlighting) functions.
Increasing numbers of moonlighting proteins—proteins that are able to perform multiple functions 
within a single polypeptide chain—are being discovered, calling for a paradigm shift in biology from 
the one protein, one function concept1–3. The apparent prevalence of moonlighting proteins adds an 
additional level of complexity to cellular physiology, and the regulation of the multiple functions of such 
proteins are not well understood4. In the case of moonlighting proteins that form part of multicompo-
nent complexes, the relative stability of the complex could form the mechanistic basis whereby such 
regulation may be achieved, especially if dissociation from the complex is an essential requirement for 
the protein to fulfil its other physiological functions.
Saccharomyces cerevisiae Hal3 (also referred to as Sis2) and Vhs3 have been classified as moonlighting 
proteins based on their dual function in both regulatory and biosynthetic pathways (Fig. 1a)5. In regards 
to regulation, these proteins have been shown to individually act as inhibitors of the Ser/Thr phosphatase 
Ppz1, which plays a role in the regulation of monovalent cation homeostasis, which impacts on cell-cycle 
control, halotolerance and cell-integrity6–9. In terms of biosynthesis, Hal3, Vhs3 and Cab3 (previously 
known as Ykl088w) form the constituent parts of a unique heterotrimeric phosphopantothenoylcysteine 
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Figure 1. The yeast PPCDC enzyme and its constituent proteins. (a) Schematic representation of 
the active PPCDC in yeast, its constituent components and the various questions surrounding their 
respective interactions. The heterotrimeric PPCDC is formed by the combination of Hal3 and/or Vhs3 
(which contributes the catalytically essential His residue, shown in blue) with Cab3 (which contributes the 
catalytically essential Cys residue, shown in orange) to give a complex with a single functional active site. 
Note that although Cab3 also has a His residue (shown in grey), it has been shown to be non-functional5. 
In addition, both Hal3 and Vhs3 also exist as homomeric trimers, and act as inhibitors of the protein 
phosphatase Ppz1 (shown in orange). Characterizing the interchange of monomers between the homo- and 
heterotrimers and the nature of the inhibitory interaction with Ppz1 is the focus of this study. (b) The 
reaction catalysed by PPCDC enzymes (in grey box) with its two-step mechanism shown on the right. Note 
that the catalytically essential His residue is important for the first step (the oxidative decarboxylation), while 
the Cys is required for the reduction of the enethiol intermediate (the second step). (c) Schematic alignment 
of the PDs of Hal3, Vhs3 and Cab3 with human PPCDC (HsCoaC). The non-homologous insertion regions 
of Hal3PD and Vhs3PD are represented in white, while the catalytically essential His (in HsCoaC, Hal3PD and 
Vhs3PD) and Cys (in HsCoaC and Cab3PD) residues are indicated in blue and orange respectively. The non-
functional His residue in Cab3PD is denoted in grey.
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decarboxylase (PPCDC) enzyme that catalyses the third step of the universal coenzyme A (CoA) bio-
synthetic pathway, namely the decarboxylation of 4′ -phosphopantothenoylcysteine (PPC) to form 
4′ -phosphopantetheine (PPantSH) (Fig. 1b).
In most eukaryotes, as typified by the human (HsCoaC) and Arabidopsis thaliana (AtHal3a) pro-
teins, PPCDC is a homotrimer with three active sites formed at the oligomer interaction interfaces10–13. 
Importantly, two catalytically essential residues—a His that is required for the first step of the enzyme’s 
two-step mechanism (an oxidative decarboxylation), and a Cys that is necessary for the second step (the 
reduction of the reaction intermediate)—are found on opposite sides of the active site, with each of the 
adjacent protomers donating one of these residues14. However, not one of the yeast proteins contains both 
catalytically essential residues. Instead, Hal3 and Vhs3 only contain the His, while Cab3 has the requisite 
Cys residue, in addition to a non-functional His5. Consequently, the homotrimeric versions of these pro-
teins cannot and do not show any PPCDC activity. Instead, in the heterotrimeric protein a single active 
site is formed per trimer at the interface between adjacent Hal3/Vhs3 and Cab3 protomers (Fig. 1a).
Sequence analysis suggests that Hal3, Vhs3 and Cab3 are structurally related, exhibiting three distinct 
domains: an N-terminal domain without significant sequence homology outside of yeasts, a PPCDC 
domain (PD) with high sequence homology to known PPCDCs, and a highly acidic C-terminal tail. 
Functional mapping of the three domains of Hal3 revealed that the presence of its PD is the mini-
mum requirement for PPCDC activity, although the N-terminal domain appears important in stabilizing 
interactions between Hal3 and Cab315. The PD is also essential for binding to Ppz1, while the N- and 
C-terminal domains are required for Ppz1 inhibition6,15. Mutagenesis studies of Hal3’s PD indicated 
that some of the residues that are functionally important for Ppz1 inhibition are also associated with, 
although not essential for, PPCDC function5,6. Moreover, it still remained unknown whether Hal3 inter-
acts with Ppz1 as a monomer or as a trimer.
The studies described above raise several questions about the mechanism regulating the dual func-
tions of Hal3 and Vhs3. Specifically: does the Hal3/Vhs3/Cab3 heterotrimer represent the major cellular 
pool from which these proteins dissociate to exert their Ppz1 inhibitory functions? If so, this would 
require the formation of PPCDC heterotrimers to be a dynamic process. However, if they are stable 
once formed, would that indicate that a heterogenous population is present that consists of heterotrimers 
acting as PPCDC enzymes, and more labile Hal3 and Vhs3 homotrimers that serve the requirement for 
Ppz1 inhibitors? In the light of our current lack of understanding of the regulatory mechanisms of moon-
lighting proteins in general, these questions hold special interest as the Hal3/Vhs3/Cab3 oligomerisation 
dynamic could form the basis for the manner in which Hal3 and Vhs3’s relative participation in CoA 
biosynthesis compared to cellular regulation is controlled.
In this study we set out to find answers to these questions, first by defining the stoichiometry of Ppz1 
and Hal3 interaction and then by studying the interaction of PDs of Hal3, Vhs3 and Cab3. Our use of 
the PDs as a model system was based on previous observations that the Hal3 PD is sufficient for both 
its PPCDC function and its ability to bind to Ppz115. Additionally, the available structural data of known 
homotrimeric PPCDCs—such as HsCoaC and AtHal3a10,11—and the high sequence homology of the 
Hal3, Vhs3 and Cab3 PDs to these known PPCDCs, suggest that the PD is primarily responsible for 
determining the oligomerisation state and PPCDC activity of these proteins (and their complexes). We 
therefore investigated the Hal3, Vhs3 and Cab3 PD proteins by a variety of biochemical and biophysical 
techniques including PPCDC activity assays, size exclusion chromatography (SEC) and circular dichro-
ism (CD). Our results show that there are significant structural differences between Hal3 and Vhs3, and 
that oligomeric mixtures made up of these proteins exhibit different thermal stabilities based on their 
composition, as well as varying abilities to undergo monomer exchange. These findings point to the 
dynamic interchange of oligomer subunits as a significant factor in the functional regulation of these 
proteins’ moonlighting functions.
Results
Elucidation of the Ppz1-Hal3 complex stoichiometry. The composition of the Ppz1-Hal3 complex 
was initially investigated in a pull-down assay by passing Hal3 (obtained from GST-Hal3 by PreScission 
protease treatment) over GST-Ppz1Cter bound to glutathione-agarose beads. The use of Ppz1Cter instead of 
the entire Ppz1 protein was based on the observation that its binding to Hal3 is facilitated by removal of 
the Ppz1 N-terminal extension, which likely acts as a protective domain1,9,16. Diverse Ppz1Cter/Hal3 ratios 
were used, ranging from 0.5-fold to a 6-fold excess of Hal3, followed by washing off unbound Hal3 and 
recovery of the Ppz1-Hal3 complex. The complex was analysed by SDS-PAGE to evaluate the relative 
amounts of Hal3 and Ppz1 (Fig. 2a). Even in the presence of a substantial excess of Hal3 in the mixture, 
the Hal3/Ppz1Cter ratio did not even reach unity, instead showing a maximum of around 0.5 (Fig.  2b). 
This suggests that the binding conditions may be non-optimal, possibly due to steric effects caused by 
the binding of GST-Ppz1Cter to the beads.
To further investigate the nature of the complex, we attempted its co-purification. For this purpose we 
co-expressed an N-terminally 6 × His-tagged version of Ppz1Cter and an untagged version of Hal3 from 
the plasmid pETDuet-1 which has two multiple cloning sites, each with their own promoter and ribo-
some binding site. The Ppz1Cter–Hal3 complex was purified by immobilized metal affinity chromatogra-
phy (IMAC) using Ni2+-based affinity resins and concentrated. When this sample was subjected to SEC 
a single major peak with an apparent molecular weight of ~165 kDa was recovered (Fig. 2c). SDS-PAGE 
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analysis of the column fractions (Fig. 2d) revealed that the peak contained Hal3 and Ppz1Cter in a ratio 
of nearly 1:1 (based on densitometric analysis and correcting for the relative fraction of residues known 
to bind Coomassie-Blue). While the apparent complex size is larger than the expected size for a 1:1 
complex of Hal3 and Ppz1 monomers (~100 kDa), it is smaller than alternative 1:1 complexes (eg. two 
or three subunits of each protein). It is important to note that we found that purified Hal3 also elutes on 
SEC with an apparent size substantially larger (~104 kDa, not shown) than its actual MW (64 kDa), most 
Figure 2. Defining the Ppz1/Hal3 complex stoichiometry. (a) Increasing amounts of recombinant Hal3 
were incubated with GST-Ppz1Cter bound to glutathione-agarose beads. After recovering the flow-through 
and washing, the beads were resuspended in Laemmli buffer, boiled, and aliquots (60 μ L) of the supernatant 
analyzed by 8% SDS-PAGE followed by Coomassie staining. The upper panel shows the amounts of Hal3 
bound by GST-Ppz1Cter, whereas the lower panel illustrates the amounts of unbound Hal3 present in the 
flow-through (40 μ L samples). The first 2 lanes include samples (2 μ g) of GST-Ppz1Cter and Hal3 proteins 
used in the experiment (note that the band present in the GST-Ppz1Cter sample that is similar in size to Hal3 
is in fact the E. coli DnaK chaperone, as established by mass spectrometry analysis). Bands corresponding 
to Hal3 are identified with a closed arrow; GST- Ppz1Cter with an open arrow. Molecular weight (MW) is 
in kilodalton (kDa). (b) The relative ratio bound Hal3/GST-Ppz1Cter was obtained by scanning the stained 
gels and integrating the relevant signals with Un-Scan-It Gel (Silk Scientific) software. Data represents 
the mean ± SD from two independent experiments. (c) 6 × His-Ppz1Cter and Hal3 were co-expressed from 
plasmid pETDUET-1, the complex recovered by Ni2+-affinity chromatography and concentrated (“sample” 
in panel D). The sample was subjected to SEC (Superdex 200) and the shown A280 elution profile was 
recorded. Arrows indicated the void volume (V0) and the elution volumes (Ve) of known proteins: bovine 
serum albumin (BSA, 67 kDa), ovalbumin (Ovo, 43 kDa) and cytochrome C (Cyt.C, 12.3 kDa). The elution 
volumes of recombinant Ppz1Cter (42.3 kDa) and Hal3 (64 kDa) are also shown; note that the latter elutes 
with a Ve equivalent to that of a ~104 kDa protein. The numbers denote the fractions collected. (d) The 
indicated fractions (1 mL) in panel C were collected; 10 μ L of each was subjected to 10% SDS-PAGE analysis 
and stained with Instant Blue (Expedeon). Note the similar intensity of the bands at ∼ 66 kDa (Hal3) (◀) and 
∼ 40 kDa (6 × His-Ppz1Cter) (◁), indicating a 1:1 protein ratio in the eluted complex. MW, molecular weight 
markers.
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likely due to the non-globular nature of its N- and C-terminal domains. Consequently, its presence in the 
Ppz1Cter–Hal3 complex is probably responsible for the anomalous elution behaviour of this combination.
Taken together, our data strongly suggest a 1:1 binding interaction for Hal3 and Ppz1, supporting the 
hypothesis that the Hal3 monomer (and not its previously characterized homotrimeric version5,15) acts 
as a Ppz1 inhibitor. This notion is further supported by the previous observation that the combination 
of equivalent amounts of Hal3 and Ppz1Cter result in near complete inhibition of the latter’s phosphatase 
activity7,9,17. This finding has far-reaching implications, as it indicates that Hal3 must abandon its role 
as a member of the heterotrimeric yeast PPCDC or dissociate from its homotrimeric form through 
de-oligomerization to fulfil its role as inhibitor of Ppz1. To investigate this further, we set out to prepare 
the PD versions of the constituent members of the yeast PPCDC to determine if these proteins could act 
as suitable models to study this phenomenon.
Expression and purification of the PDs of Hal3, Vhs3 and Cab3. The PDs of Hal3 (Hal3PD) and 
Vhs3 (Vhs3PD) were successfully expressed in high yield as N-terminal 6 × His-fusions from cultures 
transformed with the relevant plasmids. The expression of the PD of Cab3 (Cab3PD) did, however, pres-
ent greater difficulty. Numerous attempts to express Cab3PD by varying temperature and IPTG induction 
concentrations, or by using expression plasmids with different promoters (T7 and trc-based) or that 
encode different fusion tags (i.e. 6 × His, glutathione S-transferase, NusA and maltose binding protein) 
did not result in in the production of purifiable protein (data not shown). This suggests that the PD of 
Cab3 is either not successfully translated or immediately degraded upon expression in the heterologous 
host.
We next attempted to prepare Cab3PD through the same co-expression strategy used to study the 
Hal3/Ppz1Cter complex. To this end untagged Cab3PD was co-expressed with either 6 × His-Hal3PD or 
6 × His-Vhs3PD using the same pETDuet-1 system, described above. Gratifyingly, Cab3PD was found 
to give significant expression in both cases, although considerably more total protein was obtained 
from co-expression with 6 × His-Hal3PD than with 6 × His-Vhs3PD. We were able to co-express all three 
proteins by co-transforming a plasmid encoding Vhs3PD with the plasmid expressing both Hal3PD and 
Cab3PD.
The expressed proteins were subsequently purified using Ni2+-based IMAC. SDS-PAGE analysis 
(Fig. 3a) shows that the untagged Cab3PD that was co-expressed with the His-tagged Hal3PD or Vhs3PD 
(either separately, or in combination) co-purifies with the tagged proteins, providing strong evidence that 
it forms a strong interaction with both Hal3PD and Vhs3PD. The difficulty that was experienced in express-
ing Cab3PD in the absence of either of the other PD proteins is therefore most likely due to it requiring 
interaction with Hal3PD or Vhs3PD for structural stability. This analysis is supported by a recent report 
suggesting that Cab3’s ability to form stable homomeric complexes requires its N-terminal domain18.
Densitometric analysis of the bands corresponding to the purified proteins in the various mixtures 
also indicates that in the case of the two binary mixtures (Hal3PD/Cab3PD and Vhs3PD/Cab3PD), Hal3PD 
and Vhs3PD is present in at least two-fold excess compared to Cab3, while for the ternary mixture the 
ratio of Hal3PD:Vhs3PD:Cab3PD is approximately 2:1:1 (Fig.  3a). This would suggest that the minimal 
heteromeric complex formed in each case would be (Hal3PD)2/Cab3PD, (Vhs3PD)2/Cab3PD and Hal3PD/
Vhs3PD/Cab3PD respectively, although the excess of Hal3PD in the ternary mixture suggest that more 
than one type of complex might be present in this case (such as a combination of (Hal3PD)2/Cab3PD and 
Hal3PD/Vhs3PD/Cab3PD).
The PDs of Hal3, Vhs3 and Cab3 contain the structural elements required for PPCDC activity 
and trimerisation. To investigate the composition and identity of the PD complexes further, PPCDC 
activity and oligomer characterization studies were performed. The PD constructs exhibited a similar 
PPCDC activity profile (Fig.  3b) to that previously observed for the full-length proteins5, confirming 
that an active complex is formed in the presence of Cab3PD and either Hal3PD or Vhs3PD. This indicates 
that the PDs of these proteins are sufficient for PPCDC activity as expected from sequence homol-
ogy studies. Furthermore, the observation of activity suggests that the PDs also contains the structural 
elements required for trimerisation, as the active sites of the yeast PPCDC are found at the interface 
between adjacent monomers and are therefore only properly constituted in the trimeric protein5. This 
result also confirms our previous observation that the Hal3PD can interact with the full-length Cab3 to 
yield a protein complex with PPCDC activity15. We observed similar levels of activity with the different 
Cab3PD containing mixtures, which contrasts with the results obtained with the full length proteins where 
the Vhs3/Cab3 heterotrimer showed significantly reduced activity5. The comparable activity levels of 
Hal3PD/Cab3PD and Vhs3PD/Cab3PD could suggest increased stability of the latter complex compared to 
its full-length equivalent.
The ability of the PDs to form oligomers was investigated in more detail by means of cross-linking stud-
ies and SEC. Chemical cross-linking experiments were performed with disuccinimydyl suberate (DSS), 
a compound that reacts with primary amine groups (including lysine side-chains and the N-termini 
of polypeptides) to form amide bonds. SDS-PAGE analyses of DSS-treated 6 × His-Hal3PD (Fig.  4a), 
with a monomeric molecular weight (MW) of 29.1 kDa, yields two species with MWs of 50–60 kDa 
and 85–100 kDa respectively, which corresponds well with the expected MWs of dimers (58.2 kDa) and 
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trimers (87.3 kDa). Similar results were obtained with 6 × His-Vhs3PD, which has a monomeric MW of 
34.5 kDa. Two species with MWs of 60–70 kDa and 100–120 kDa are observed by SDS-PAGE, corre-
sponding to the expected respective molecular weights of dimers (69 kDa) and trimers (103.5 kDa). The 
observed dimers are most likely formed due to incomplete cross-linking.
SEC studies of the Hal3PD and Vhs3PD proteins (Fig.  4c,d) and the Hal3PD/Cab3PD and the Hal3PD/
Vhs3PD/Cab3PD mixtures (Fig.  4e,f) support the conclusions drawn from the cross-linking results (the 
Vhs3PD/Cab3PD mixture was not included in this analysis, due to the low expression levels for this com-
plex limiting the amount of protein available for analysis). For these studies, the human PPCDC HsCoaC, 
which has previously been shown to form a trimer, was used as positive control (Fig.  4b). In all cases 
the MW of the major oligomeric species corresponded to the MW of the expected trimeric complex, 
except for the Hal3PD/Cab3PD complex (Fig.  4e), where an apparent hexameric (or dimer of trimers) 
species predominates. Hal3PD (Fig. 4c) and the HsCoaC control (Fig. 4b) were also found to form higher 
oligomeric structures, including hexamers and dodecamers, while in the case of Vhs3PD (Fig.  4d) and 
the Hal3PD/Vhs3PD/Cab3PD mixture (Fig. 4f) only trimeric complexes were observed. While the ternary 
mixture only shows a single peak that corresponds closely with the expected MW of the Hal3PD/Vhs3PD/
Cab3PD trimer, the low resolution of the SEC analysis makes it impossible to exclude the possibility that 
(Hal3PD)2/Cab3PD trimers are present as well.
Vhs3PD differs from Hal3PD based on secondary structure and mode of flavin binding. Having 
established that the PD proteins reflect the same activity and oligomerization characteristics as their 
native counterparts, we next set out to study their structural features as possible basis for the modulation 
of their oligomer stability. The secondary structure of the various PD domains and their corresponding 
complexes were studied by CD spectroscopy in the far-UV range. The obtained CD spectra (Fig. 5a) sug-
gest that the proteins differ in secondary structure, most likely due to differences in the non-homologous 
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Figure 3. SDS-PAGE and PPCDC activity analyses of purified PD proteins. (a) SDS-PAGE analysis 
(using a 12% gel) of ~5 μ g of each of the pure PD proteins or the indicated mixtures. Lane 1, 6 × His-Hal3PD 
(expected MW: 29.1 kDa); lane 2, 6 × His-Vhs3PD (expected MW: 34.5 kDa); lane 3, co-expressed 6 × His-
Hal3PD/Cab3PD (expected Cab3 MW: 23.3 kDa); lane 4, co-expressed 6 × His-Vhs3PD/Cab3PD; lane 5, co-
expressed 6 × His-Hal3PD/6 × His-Vhs3PD/Cab3PD; MW, molecular weight markers with molecular weights 
indicated. (b) In vitro PPCDC activity of ~60 nM of either HsCoaC, Hal3PD (H), Vhs3PD (V), Hal3PD/Cab3PD 
(H + C), Vhs3PD/Cab3PD (V + C), and co-expressed Hal3PD/Vhs3PD/Cab3PD (H + V + C). The data represent 
the average of three separate experiments, with the error bars showing the standard deviation.
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Figure 4. The PDs of Hal3, Vhs3 and Cab3 form trimers. (a) SDS-PAGE analyses (8% gel) of DSS-treated 
6 × His-Hal3PD (expected MWs: 58.2 kDa (dimer), 87.3 kDa (trimer)) and 6 × His-Vhs3PD (expected MWs: 
69.2 kDa (dimer), 103 kDa (trimer)). (b–f) Size exclusion chromatography (SEC) analyses of the purified 
PD proteins and mixtures: (b) HsCoaC; expected MWs: 25.6 kDa (monomer), 76.8 kDa (trimer) (c) Hal3PD; 
expected MWs: 29.1 kDa (monomer), 87.3 kDa (trimer), 153 kDa (hexamer), 349.2 kDa (dodecamer) (d) 
Vhs3PD; expected MWs: 34.6 kDa (monomer), 103 kDa (trimer) (e) Hal3PD/Cab3PD; expected MW: 26.2 kDa 
(average monomeric MW), 78.6 kDa (2 × Hal3PD/1 × Cab3 trimer); 157.2 kDa (4 × Hal3PD/2 × Cab3 
hexamer) (f) Hal3PD/Vhs3PD/Cab3PD; expected MWs: 29 kDa (average monomeric MW), 87 kDa 
(1 × Hal3PD/1 × Vhs3PD/1 × Cab3 trimer).
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inserts found in Hal3 and Vhs3 as the proteins share a high level of sequence similarity in other regions 
(Fig. 1c). Oligomers of Hal3PD as well as the Vhs3PD/Cab3PD mixture are primarily α -helical as indicated 
by the absorbance bands at 208 and 222 nm. Vhs3PD appears to be structurally different from Hal3PD and 
other typical α -helical proteins due to the greater intensity of the 208 nm band relative to the 222 nm 
band in its case. Furthermore, introduction of Cab3PD into the complex affects the global secondary 
structure as a decrease in the intensity of the 208 nm band is observed in the Hal3PD/Vhs3PD/Cab3PD and 
Hal3PD /Cab3PD in comparison to Hal3PD alone, while a decrease in the 222 nm band is observed in the 
case of Vhs3PD/Cab3PD in comparison to Vhs3PD only. This suggests that Cab3PD is structurally different 
from both Hal3PD and Vhs3PD, and/or that the introduction of Cab3PD into the oligomers results in con-
formational changes in the proteins involved in the formed heterotrimer.
The CD spectra of flavoproteins in the visible range provide a sensitive indication of differences in 
these proteins’ binding of their flavin cofactor19. Since the flavins of PD proteins are bound in the active 
sites that are found at the trimer interfaces, analysis of the CD and UV-visible absorption spectra of 
these proteins should provide an indication of the differences and similarities of their respective subunit 
interactions. The flavin CD spectra of the purified PD proteins and the various mixtures were therefore 
obtained (Fig. 5b). Although these spectra overall show a high level of similarity, in the case of Vhs3PD a 
slight red shift can be observed for the absorption band that is found at ~375 nm in the other proteins. 
The slight red shift is also observed in the absorbance maximum of the ~375 nm peak in the correspond-
ing absorbance spectrum (obtained simultaneously with the CD spectra) of Vhs3PD compared to those 
of the other proteins and mixtures (Fig. 5c). An additional low intensity absorption band is also visible 
at ~465 nm in the Vhs3PD flavin CD spectrum and in those of the heteromeric complexes containing 
Vhs3PD (Fig. 5b). These differences suggest that the intersubunit interactions in oligomers that contain 
Vhs3PD are dissimilar from those found in Hal3PD, either on its own or in complex with Cab3PD.
Heat-induced secondary structure changes reveal differences in the thermal stability of the 
trimeric complexes. Oligomer thermal stability based on changes in secondary structure was inves-
tigated by studying changes in the CD signal at 222 nm—the wavelength normally used for studying 
proteins that largely consist of α -helices20—as a function of temperature. The obtained data were con-
verted to represent the fraction of folded protein (see Experimental for details), which gave the protein 
melting curves represented in Fig. 6a. The corresponding first derivative plots of these melt curves are 
given in Fig. 6b; these were used to estimate the melting temperatures (Tm) in each case, as many of the 
obtained curves exhibited multiple inflection points (suggesting several separate structural changes) that 
prevented a single equation from being fitted to the data. Importantly, protein unfolding was found to 
occur irreversibly due to protein precipitation, precluding the calculation of thermodynamic constants 
from the obtained data21. The various Tm-values obtained in this manner are summarised in Table 1.
Comparison of these values indicate that Hal3PD and Vhs3PD exhibit dramatically different stabilities 
as demonstrated by their Tm-values of ~45 oC and 78 oC respectively, which correspond to the lowest 
and highest values determined for any of the proteins and mixtures. Vhs3PD exhibited two Tms that are 
similar in value to the two Tms determined for HsCoaC (the known human PPCDC). However, in both 
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Figure 5. Vhs3 has a different secondary structure composition and mode of flavin binding. (a) CD 
spectra of Hal3PD (H), Vhs3PD (V), Hal3PD/Cab3PD (H + C), Vhs3PD/Cab3PD (V + C), and co-expressed 
Hal3PD/Vhs3PD/Cab3PD (H + V + C) in the UV range, highlighting the differences and similarities in their 
secondary structures. (b) CD spectra of the same proteins and mixtures obtained in the visible range, 
showing the differences and similarities in the environments of their flavin cofactors. The vertical dotted 
line shows the absorbance maximum of all the proteins—with the exception of Vhs3PD—at 375 nm. (c) 
Absorbance spectra obtained simultaneously with the CD spectra in panel b. The legend is identical to that 
shown in (b).
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cases the lower value is based on a low intensity peak in the first derivative curves (i.e. a minor change 
in the heat-induced melt curves, most likely associated with a minor structural change). In contrast 
three apparent Tm-values can be determined for Hal3PD (Fig.  6b), with the lowest of the three most 
probably being the functionally relevant value. This conclusion is based on the finding that the higher 
values correlate with a distinctive reduction in this protein’s absorbance (starting at ~55 °C) that is likely 
due to protein precipitation and the subsequent settling of the precipitate in the cuvette (Supplementary 
Fig. S1). Taken together, this indicates that Vhs3PD forms the most stable protein complexes, while the 
Hal3PD complexes are the least stable. Correspondingly, Cab3PD’s complexes with Vhs3PD are much more 
stable than with Hal3PD; in fact, addition of Cab3PD to homomeric Vhs3PD lowered the latter’s major Tm 
by ~5 °C, while for Hal3PD the presence of Cab3PD had a stabilizing effect, increasing its Tm by ~10 °C. 
Predictably, the ternary Hal3PD/Vhs3PD/Cab3PD complex showed intermediate stability compared to the 
two binary complexes.
The Hal3PD/Vhs3PD/Cab3PD-mixture exhibited two distinct peaks of similar intensity, which sug-
gests that the complex formed in its case either undergoes two distinct temperature-induced structural 
changes, or that the mixture contains two different protein complexes. Since the SDS-PAGE analysis 
of the purified Hal3PD/Vhs3PD/Cab3PD protein mixture indicated that that Hal3PD is present in at least 
two-fold excess compared to the other two proteins (refer Fig. 3a), it is likely that this mixture contains 
two active heterotrimers, i.e. Hal3PD/Vhs3PD/Cab3PD and (Hal3PD)2/Cab3PD. This analysis is supported by 
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Figure 6. Heat-induced denaturation of the PD proteins is preceded by flavin release. (a) Melting curves 
of HsCoaC and Hal3PD (H), Vhs3PD (V), Hal3PD/Cab3PD (H + C), Vhs3PD/Cab3PD (V + C), and co-expressed 
Hal3PD/Vhs3PD/Cab3PD (H + V + C) as determined by the changes in the proteins’ molar elipticity at 222 nm. 
The curves represent the fraction folded protein as a function of temperature. (b) First derivative plots of the 
melting curves shown in panel a, smoothed using the standard settings in SigmaPlot 11. (c) Plots of changes 
in the molar elipticity measured for the indicated proteins at 320 nm as a function of temperature; the curves 
represent the best fits of the Gibbs-Helmholtz equation to the data (see Methods for details).
Protein/Mixture
Tm based on 
secondary structure 
changesa (CD at 
222 nm)
Tm based 
on flavin 
releaseb (CD 
at 320 nm)
Tm1 Tm2 Tm3 Tm
HsCoaC 65.6 75.5 – 70.2
Hal3PD 45.0 60.1 67.6 41.2
Vhs3PD 63.2 78.4 – 78.1
Hal3PD/Cab3PD 55.8 – – 47.1
Vhs3PD/Cab3PD 56.8 73.5 – ndc
Hal3PD/Vhs3PD/Cab3PD 57.7 68.5 – 53.8
Table 1.  Tm-values determined based on the heat-induced changes in the PD proteins’ secondary 
structures and the heat-induced release of their flavin cofactors. aDetermined from the maxima observed 
in the first derivative plots (Fig. 6b) of the heat-induced melt curves shown in Fig. 6a. The value in bold 
indicates the value that is most likely physiologically relevant (see text for details). bDetermined by fitting the 
data shown in the plots in Fig. 6c to the Gibbs-Helmholtz equation (see Experimental for details). cnd, not 
determined.
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the finding that the Hal3PD/Cab3PD mixture shows only a single Tm that matches the value of the lowest 
Tm observed for the Hal3PD/Vhs3PD/Cab3PD mixture (Table  1), leading us to conclude that this value 
most likely represents the Tm of the (Hal3PD)2/Cab3PD complex, while the higher value represents the 
true Hal3PD/Vhs3PD/Cab3PD Tm.
Heat-induced flavin release by the trimeric complexes precedes denaturation in some 
cases. The finding that some the proteins and mixtures exhibit multiple apparent Tm-values was not 
completely unexpected, since it is also possible that at least in some instances the trimeric proteins first 
dissociate into their constituent subunits, and that this is then followed by the major gross structural 
changes that lead to denaturation. Since the models of the trimeric PPCDC and related enzymes all indi-
cate that the flavin binding site is located at the interface of the subunits (Fig. 1a)10,11, one would predict 
that dissociation of the oligomeric complexes would lead to exposure of the flavin cofactor to solvent and 
its release from the protein complex. Importantly, free flavin is known to exhibit low levels of ellipticity, 
while the binding of flavin to a protein significantly increases the intensity of its CD spectrum due to the 
restrictive and asymmetric nature of the binding site19. We therefore evaluated the heat-induced changes 
in the molar ellipticity of the various proteins’ flavin cofactors to determine whether dissociation of the 
protein complexes precedes or accompanies the unfolding/denaturation.
The flavin CD spectra of the PD proteins were found to show the largest heat-induced changes in 
molar ellipticity at ~320 nm (Supplementary Fig. S2); consequently, readings at this wavelength were 
obtained for each of the proteins and mixtures at increasing temperatures. The readings were converted 
to the fraction of protein-bound flavin, giving the plots shown in Fig. 6c. The respective Tm-values (only 
one in each case) were obtained by fitting of the Gibbs-Helmholtz equation (see Experimental for details) 
(Table 1), and were found to follow the same trend as determined from the secondary structure changes. 
More specifically, the data confirm that Hal3PD is the least stable and Vhs3PD the most stable of the PD 
proteins, with complexes that contain Cab3PD having intermediate stability. Moreover, comparison of the 
flavin release-based Tm-values to the Tms obtained from the secondary structure-based changes indicated 
that in most instances flavin release (and therefore trimer dissociation) occurs first, followed by dena-
turation at higher temperatures. Vhs3PD was the only protein for which the two values were found to 
coincide, indicating that release of its flavin cofactor requires unfolding and denaturation. It is therefore 
unlikely to exchange subunits with other trimeric complexes. In contrast, these findings suggest that sub-
unit dissociation (and therefore subunit exchange) is a likely event in the case of Hal3PD and the Hal3PD/
Cab3PD mixture. For the Hal3PD/Vhs3PD/Cab3PD mixture our analysis of the secondary structure-based 
changes suggested that two complexes—i.e. Hal3PD/Vhs3PD/Cab3PD and (Hal3PD)2/Cab3PD—are present. 
However, only a single flavin release-based Tm-value is observed in its case. This would suggest that of the 
two only (Hal3PD)2/Cab3PD is susceptible to subunit dissociation, or that the two complexes’ susceptibility 
to dissociation is indistinguishable.
Heterotrimeric complexes exhibit different abilities to undergo subunit exchange. To fur-
ther investigate the propensity of the heterotrimeric (Hal3PD)2/Cab3PD and Hal3PD/Vhs3PD/Cab3PD com-
plexes to undergo monomeric subunit exchange, PPCDC inactive forms of the complexes were prepared 
by mutation of the catalytically essential His residue in either Hal3PD or Vhs3PD to alanine to form 
Hal3PD_H378A and Vhs3PD_H459A respectively. These complexes were subsequently titrated with either native 
Hal3PD or Vhs3PD, incubated for 10 minutes, and then analysed for their PPCDC activity. We expected to 
only observe PPCDC activity in the instances that the native proteins displaced their mutated counter-
parts by dissociation and subunit exchange, with the relative magnitude of the PPCDC activity providing 
an indication of the extent of exchange.
For the Hal3PD_H378A/Cab3PD mixture we observed a significant increase in the activity upon incuba-
tion with an excess of Hal3PD, indicating successful subunit exchange between the respective oligomers 
(Fig.  7). Similarly, we observed activity upon treatment of the same mixture with Vhs3PD, although in 
this case the observed increase in activity was markedly less than what was seen for Hal3PD. This is most 
likely caused by lower levels of exchange between Vhs3PD and the (Hal3PD_H378A)2/Cab3PD trimer due to 
the higher stability (and low exchange susceptibility) of the Vhs3PD homotrimer compared to its Hal3PD 
counterpart. Although it could also be argued that incorporation of Vhs3PD leads to formation of a 
complex with an inherently lower PPCDC activity, we consider this a highly unlikely possibility based 
on the finding that the different heterotrimeric complexes showed comparable levels of activity (Fig. 3b), 
and the previous observation that incorporation of Vhs3 into a heterotrimer of the full length proteins 
resulted in an increase in PPCDC activity compared to that seen for a Hal3/Cab3 heterotrimer5.
Importantly, the inactive Hal3PD_H378A/Vhs3PD_H459A/Cab3PD mixture only showed PPCDC activ-
ity upon titration with Hal3PD, and at much lower levels than that seen upon titration of the Hal3PD_
H378A/Cab3PD mixture with the same protein (Fig.  7). This indicates that the Hal3PD/Vhs3PD/Cab3PD  
hetero-trimer is less susceptible to subunit exchange, and supports the interpretation of the flavin release 
experiments that the single Tm-value is associated with the dissociation of the (Hal3PD)2/Cab3PD complex 
present in such mixtures. It is in fact very likely that the PPCDC activity observed upon titration of 
the Hal3PD_H378A/Vhs3PD_H459A/Cab3PD mixture with Hal3PD is due to exchange of (Hal3PD_H378A)2/Cab3PD 
present in the mixture, although currently we are unable to demonstrate this experimentally.
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Discussion
Although the disparate and non-overlapping activities of the S. cerevisiae Hal3 and Vhs3 proteins—
either as constituents of a unique heterotrimeric PPCDC involved in CoA biosynthesis, or as regulatory 
subunits of the Ppz1 phosphatase—clearly identifies them as moonlighting proteins, the lack of struc-
tural information on these proteins made it difficult to rationalize the molecular basis whereby these 
activities are differentiated. Based on previous studies that showed that the Vhs3–Ppz1 interaction has 
a much smaller physiological relevance in vivo than that of Hal3–Ppz16,7, this study was initiated by an 
investigation of the latter complex. The evidence presented here that Hal3 and Ppz1 interacts with a 1:1 
stoichiometry (i.e. that Hal3 inhibits Ppz1 as monomer), provided the starting point for studying the 
possible dynamic exchange of Hal3 and Vhs3 among the relevant protein complexes.
In this study we investigated the activity, structure, thermal stability and exchange reactions of 
hetero-trimers of the Hal3, Vhs3 and Cab3 PDs in an attempt to gain a better understanding of the fac-
tors that affect the formation of the active PPCDC enzyme, and whether oligomerization dynamics could 
act as a putative regulatory mechanism. The PDs did prove to be suitable model constructs, as our data 
show that they are sufficient for PPCDC activity (Fig. 3b). Furthermore, Cab3PD forms a strong interac-
tion with Hal3PD/Vhs3PD as evidenced by the fact that untagged Cab3PD co-purified with 6 × His-tagged 
Hal3PD/Vhs3PD (Fig. 3a). This observation, in combination with cross-linking, SEC and PPCDC activity 
results (Fig. 4), indicates that the PDs also contain the structural elements required for oligomerisation. 
Combined, these experiments suggest that study of the oligomeric nature of the PD complexes should 
be relevant and applicable to the PPCDC complex formed by the full-length proteins, and to the ability 
of Hal3 and Vhs3 to dissociate from it.
In light of their high sequence homology (Vhs3PD exhibit 62% sequence identity in comparison with 
Hal3PD), we were surprised to find that the Hal3 and Vhs3 PDs exhibit significant structural differences 
as observed by CD studies based on both secondary structure and mode of flavin binding (Fig. 5). The 
differences apparently also translate into significant differences in thermal stability, with homomeric 
Vhs3PD exhibiting a Tm that is ~30 °C higher than that of the homomeric Hal3PD (Fig. 6). Importantly, 
the heat-induced flavin-release experiments showed that the high thermal stability of Vhs3PD makes 
it resistant to de-oligomerisation, as it only releases its flavin (bound at the subunit interfaces) upon 
denaturation of the whole complex. In contrast, the relative low stability of the Hal3PD complexes seems 
to allow them to readily release monomeric subunits. Taken together, our findings indicate that Vhs3PD 
preferentially exists as a trimer, while Hal3PD is able to interchange between monomeric and higher order 
oligomeric forms.
These differences between Hal3PD and Vhs3PD carry over to the heteromeric complexes of which 
they form part. First, the Hal3PD/Cab3PD complex is significantly more stable than Hal3PD on its own; 
however, like Hal3PD, it also readily allows dissociation of its constituent subunits (Fig.  6). This is fur-
ther underscored by the experiments in which native Hal3PD or Vhs3PD was titrated to a mixture of 
Hal3PD_H378A/Cab3PD (i.e., an inactive PPCDC complex) (Fig. 7). Addition of Hal3PD causes a significant 
increase in activity, with much lower levels seen upon addition of Vhs3PD—clearly showing that Hal3PD 
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Figure 7. The heterotrimeric complexes exhibit differences in their ability to undergo subunit exchange. 
The heterotrimers Hal3PD_H378A/Cab3PD (H* + C) and Hal3PD_H378A/Vhs3PD_H459A/Cab3PD (H* + V* + C) 
were titrated with five- and 10-fold (relative to the monomer concentration of the inactive heterotrimer) 
of either Hal3PD (H) or Vhs3PD (V). The activities (reported as nmol/min/nmol protein) were adjusted 
to the monomer concentration of the inactive heterotrimers (i.e. excess Hal3PD or Vhs3PD added was not 
considered in the calculation). The data indicated the average of an experiment performed in triplicate; the 
error bars indicate the standard deviation. Values were compared to that of the inactive control (buffer) by 
one-way ANOVA followed by Dunnet’s post-test (*p < 0.05).
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readily exchanges monomers between homomeric and heteromeric complexes, while this is not the case 
for Vhs3PD. In contrast, when the same experiment was conducted with the Hal3PD_H378A/Vhs3PD_H459A/
Cab3PD mixture the increase in activity was significantly reduced. This shows that addition of Vhs3PD 
stabilised the complex, reducing its ability to exchange monomeric subunits. This analysis is supported 
by the thermal stability data, which shows that Hal3PD/Vhs3PD/Cab3PD exhibits a higher Tm than Hal3PD/
Cab3PD.
Overall, our results show that Hal3PD- and Vhs3PD-containing heteromeric complexes exhibit differ-
ent stabilities, as well as disparate abilities to exchange their constituent monomers. While Hal3PD can 
easily exchange from complexes containing only Hal3PD and Cab3PD, the formation of the heterotrimeric 
Hal3PD/Vhs3PD/Cab3PD complex by addition of Vhs3PD makes it much more stable and less likely to show 
dynamic monomer exchange. It is important to note that the native expression of Hal3 is estimated to 
be 30-fold greater than Vhs3 (60 ppm versus ~2 ppm)22,23. It is tempting to speculate that these differ-
ences relate directly to the moonlighting roles of Hal3 and Vhs3, as indeed have been noted for other 
moonlighting proteins24. Our results suggest that Hal3 is more likely to act as Ppz1 inhibitor, while Vhs3 
is more likely to be found as a stabilizing constituent of the heterotrimeric Hal3/Vhs3/Cab3 complex, 
ensuring that a certain amount of active PPCDC is always maintained in the cell. This hypothesis fits 
with the previous observation that, in vivo, Vhs3 is less effective than Hal3 in controlling Ppz1-mediated 
functions, as deduced from the phenotypic analysis of HAL3 and VHS3 deletion or overexpressing 
strains6,7. The difference in the relative abundance of the two proteins is compatible with Hal3 perform-
ing dual roles (as Ppz1 inhibitor and as component of the yeast PPCDC), while Vhs3 mainly forms part 
of the latter. It also agrees with our finding that in heterologous expression in E. coli, recombinant Cab3 
co-expresses better with Hal3 than with Vhs3, which due to a lower stoichiometry is less likely to form 
a complex with only Cab3 (i.e. (Vhs3)2/Cab3) in vivo. The differentiation of Hal3 and Vhs3 might have 
conferred an evolutionary advantage that ensured that both proteins were maintained in the genome, 
even though they appear to exhibit similar functions in vivo, and largely equivalent properties in vitro7.
The structural basis for these differences between Hal3 and Vhs3 remain unclear. However, in spite 
of their high level of sequence similarity both proteins also contain large non-homologous insertions 
(Fig. 1c). It is possible that these regions play an important role in the stability of the enzymes, perhaps 
through their ability to form higher order oligomers (our SEC analysis data clearly shows that Vhs3PD 
only forms trimers, while Hal3PD and Hal3PD/Cab3PD also forms apparent hexamers and dodecamers; see 
Fig. 4). Such a conclusion is supported by previous SEC analysis studies of Hal3 ∆312-350 (a construct in 
which its insertion is deleted), which showed that although deletion of the region did not affect homo-
trimerisation, the ability to form higher oligomeric structures was reduced15. A recent computational 
study indicated the general validity of this observation, as it was shown that insertions and deletions in 
homologous proteins profoundly affect their oligomeric states and complex stability25.
Recently, Hal3, Vhs3 and Cab3 were described as forming part of a large CoA synthesising protein 
complex (CoA-SPC) in yeast, which also involve the CoA biosynthesis enzymes Cab2, Cab4 and Cab518. 
The existence of such a complex was previously proposed but not widely accepted as these authors also 
suggested that the complex biosynthesized CoA via an alternate pathway26,27. Olzhausen et al. system-
atically analysed interaction between the different yeast CoA biosynthesis enzymes, showing that Cab2, 
Cab3, Cab4 and Cab5 can interact with each other, supporting the existence of a large protein com-
plex18. The authors also mapped the regions of these proteins that take part in these interactions, which 
suggested that Cab3 acts as a scaffold for the complex, primarily via interactions with its N-domain. 
Importantly, Cab3 homomerisation was also found to occur via the N-domain, which likely explains 
why we were unable to purify Cab3PD on its own. These results indicate that the role of the N-domains 
of these proteins is to form and maintain the CoA-SPC in vivo.
Similarly, our previous studies on the functional mapping of the Hal3 domains showed that its 
N-terminal region is important to stabilize interaction between Hal3 and full-length Cab3, although the 
PPCDC domain was the minimal requirement for formation of the trimeric complexes containing these 
proteins15. The results of the current study provide further support for the PDs defining the primary 
nature of the Hal3/Vhs3 interaction with Cab3. Nonetheless, we cannot exclude that the presence of the 
N-terminal domain could impact on the analysis of the stabilities of the various complexes presented 
here. However, considering the high level of similarity between the N-and C-domains of especially Hal3 
and Vhs3 (the N-domain of Vhs3 is 49% identical to that of Hal3 and 61% similar, and its C-domain 
55% identical and 68% similar), we believe that while the inclusion of these domains may affect the 
absolute stability of the full length proteins, the relative stabilities should remain similar—and that the 
conclusions drawn from the study of the PD proteins should therefore also hold true for the native 
proteins. Confirmation of the binding interaction models on which these analyses are based must await 
determination of the crystal structures of the various complexes; however, in spite of significant efforts 
in this regard, we have thus far not been able to obtain such structures. Yet, it is clear that the existence 
of a large CoA-SPC makes the structural and biophysical properties of Hal3, Vhs3 and the heteromeric 
PPCDC oligomers of great interest as this likely plays a crucial role in the assembly and function of the 
CoA-SPC complex, and may increase the regulatory complexity of the moonlighting activities of Hal3 
and Vhs3 even further.
In conclusion, in this study we demonstrated that the PDs of Hal3, Vhs3 and Cab3 are the minimum 
and sufficient requirement for these proteins to show PPCDC activity by forming active heterotrimeric 
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complexes. Moreover, we show that Hal3 interacts with Ppz1 with a 1:1 ratio and that Hal3’s struc-
tural characteristics allow it to exist as a monomer that can readily be exchanged between higher order 
complexes. In contrast, Vhs3’s structure causes it to form stable complexes that are more resistant to 
monomer exchange. These findings provide the first indication of the molecular basis for differentiation 
between the homologous Hal3 and Vhs3 proteins, and give insight into a possible mechanism for the 
physiological regulation of their respective moonlighting activities. Future studies will have to address 
how such regulation occurs in vivo, including the impact of synchronized translation to ensure the simul-
taneous production of the constituent parts of the heteromeric complexes to ensure their preferential 
formation when required.
Methods
Plasmid construction. The PDs of Vhs3 (residues 288–577) and Cab3 (residues 305–508) were iden-
tified by comparison to HsCoaC, the human PPCDC (Fig. 1c). The corresponding sections of the respec-
tive genes were subsequently amplified by PCR using the previously described pGEX6P-1 vectors5 as 
templates with the oligonucleotides 5′-Vhs3CoaC, 3′-Vhs3CoaC, 5′-Ykl088wCoaC and 3′-Ykl088wCoaC 
(Supplementary Table S1). These oligonucleotides introduce NdeI and XhoI restriction sites which 
were used to subclone the obtained PCR products into the corresponding restriction sites of the kan-
amycin resistant expression plasmid pET28a (Novagen), to yield pET28a-Vhs3PD and pET28a-Cab3PD 
(Supplementary Table S2). The vector pET28-Hal3PD was constructed previously in an analogous man-
ner15. The plasmids pET28a-Hal3PD_H378A and pET28a-Vhs3PD_H459A were constructed similarly, with the 
previously described pGEX6P1-Hal3_H378A and pGEX6P1-Vhs3_H459A as templates5.
The PDs were also cloned into the ampicillin resistant co-expression vector pETDuet-1 (Novagen), 
which allows for the simultaneous expression of two proteins: the first with an N-terminal 6 × His fusion 
tag, and the second as an untagged protein. Cab3PD was subcloned from pET28a-Cab3PD into the sec-
ond multiple cloning site (MCS) of the vector using the NdeI/XhoI restriction sites. For subcloning of 
Hal3PD, Hal3PD_H378A, Vhs3PD and Vhs3PD_H459A into the first MCS, these genes were first subcloned from 
the relevant pET28a plasmids into the entry vector pENTR4T using the restriction sites NcoI and XhoI, 
and subsequently subcloned into the NcoI/BsrGI restriction sites of the first MCS of pETDuet-1. In 
this manner, the co-expression plasmids pETDuet-1_Hal3PD_Cab3PD, pETDuet-1_Vhs3PD_Cab3PD and 
pETDuet-1_Hal3PD_H378A_Cab3PD were obtained.
Plasmids pGEX6P1-Ppz1Cter and pGEX6P1-Hal3, which allows for the expression of the GST-fusions 
of Ppz1 (Δ 1–344) (carboxyl terminal domain; Ppz1Cter) and the entire Hal3, respectively, were described 
previously7. Co-expression of Ppz1Cter N-terminally fused to a 6 × His tag and the entire Hal3 was accom-
plished by cloning a Ppz1Cter fragment amplified by PCR with oligonucleotides pDuet_PPZ1Cter-5a and 
pDuet_Ppz1_T1-3 in the first MCS of pETDuet-1 (AscI/HindIII digestion), followed by subcloning the 
Hal3 fragment amplified with oligonucleotides pDuet_Hal3_5 and pDuet_Hal3_3, into the BglII/XhoI 
sites of the second MCS.
Recombinant protein expression and purification. Expression was performed in chemically 
transformed E. coli BL21 (DE3) cells grown in Luria Bertani (LB) broth supplemented with 30 mg/L 
kanamycin and/or 100 mg/L ampicilin as required. Expression and purification of GST-Ppz1Cter and 
GST-Hal3 was carried out as previously described5, except that in both cases induction was carried 
out with 0.1 mM IPTG, followed by overnight expression at 21 °C. Co-expression and purification of 
6 × His-Ppz1Cter and Hal3 was carried out in 1 L LB cultures, which was induced with 0.1 mM IPTG 
at an OD600 ~0.8–1.0, followed by overnight expression at 18 °C. Cells were collected by centrifuga-
tion at 3600 × g for 1 h at 4 °C and pellets resuspended in 30 mL of binding buffer (50 mM Tris-HCl, 
pH 7.5, 300 mM NaCl, 10 mM imidazole) supplemented with 0.1% Triton X-100 and protease inhibitor 
cocktail (Mini EDTA-free, Roche). The suspension was sonicated and centrifuged at 4 °C (12400 × g for 
30-40 minutes), followed by Ni2+-affinity chromatography (His-Trap column, GE Healthcare) using an 
ÄKTA Purifier 100 system (GE Healthcare). After loading, the column was sequentially washed with 
binding buffer supplemented with 30, 60, and 80 mM imidazole (10 mL each, 1 mL/min), after which the 
protein complex was eluted with the same buffer containing 500 mM imidazole (1 mL/min). The fractions 
were adjusted to 5 mM EDTA and 2 mM DTT and stored at 4 °C. For size exclusion chromatography 
(SEC) the relevant fractions were pooled and concentrated to a volume of 500 μ L by centrifugation in a 
Vivaspin 6 (50 MW cut-off, Sartorius) device. SEC was carried out by using a Superdex 200 HR 10/30 
column (GE Healthcare) at a flow rate of 0.5 mL/min (1 mL fractions) with a buffer consisting of 50 mM 
Tris-HCl (pH 7.5), 270 mM NaCl, 2 mM DTT and 2 mM EDTA.
Large scale expression of 6 × His-Hal3PD was performed as previously described15, while 6 × His-Vhs3PD 
was successfully purified by using an identical protocol. Briefly, these proteins were expressed in 500 mL 
LB, induced with 0.2 mM IPTG at OD600 ~ 0.6 and allowed to grow overnight at 25 °C. A mixture 
of 6 × His-Hal3PD and Cab3PD, and of 6 × His-Vhs3PD and Cab3PD, were expressed from the respective 
pETDuet-1 plasmids by induction of the cultures with 0.05 mM IPTG at OD600 ~0.6, followed by over-
night incubation at 37 °C. A mixture of 6 × His-Hal3PD, 6 × His-Vhs3PD and Cab3PD was expressed from 
BL21 (DE3) cells co-transformed with pETDuet-1_Hal3PD_Cab3PD and pET28a-Vhs3PD and expressed 
using the same conditions as for the pETDuet-1 plasmids. Mixtures of the catalytically inactivated 
mutants 6 × His-Hal3PD_H378A/Cab3PD, 6 × His-Hal3PD_H378A/Vhs3PD/Cab3PD and 6 × His-Hal3PD_H378A/
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Vhs3PD_H459A/Cab3PD were obtained similarly. 6 × His-HsCoaC was expressed and purified as previously 
described28.
Successfully expressed PD proteins were purified on an ÄKTAprime system (GE Healthcare), using 
Ni2+-affinity chromatography with HiTrapFF or HiTrap chelating columns (GE Healthcare) according to 
the manufacturer’s directions. Briefly, cell pellets collected from the 500 mL expressions were re-suspended 
in binding buffer (10 mL buffer/gram of cells), sonicated and subsequently centrifuged to remove cellular 
debris. The obtained cell extracts were loaded onto the column, followed by washing with binding buffer 
and 15% elution buffer to elute non-specifically bound proteins, and subsequent elution of the protein of 
interest in 100% elution buffer. The imidazole present after elution was removed by buffer exchange to 
gel-filtration buffer using a HiTrap desalting column (GE Healthcare) on the ÄKTAprime system.
Several different buffer systems were used for purification, each consisting of a binding buffer and 
gel-filtration buffer used for final buffer exchange. In all cases the protein was eluted with 500 mM imida-
zole added to the binding buffer. “Low Tris” buffer (20 mM Tris-HCl, pH 7.9, 500 mM NaCl, 0.05% (w/v) 
NaN3), and gel-filtration to 25 mM Tris-HCl, pH 8.0, 5 mM MgCl2 was used for the general purification 
of Hal3PD and Vhs3PD. A phosphate buffer (20 mM phosphate, pH 7.4, 500 mM NaCl) and gel-filtration 
to 25 mM phosphate, pH 7.4, 5 mM MgCl2 was used for general purification of the co-expressed proteins, 
which tends to precipitate upon purification with Low Tris buffers. Finally, “High Tris” buffer (50 mM 
Tris-HCl, pH 8, 500 mM NaCl, 10% glycerol, 0.05% (w/v) NaN3) and gel-filtration to 50 mM Tris-HCl, pH 
8, 150 mM NaCl, 10% glycerol was used for the CD spectroscopic studies due to increased protein stability.
Protein concentration determination. Protein concentration was determined by means of the 
Bradford assay29 modified for use in a 96-well plate, and by a microbiuret assay30 for the circular dichroism 
studies, due to the reduced sensitivity of this assay to differences in protein sequence. For GST-Ppz1Cter 
and Hal3 binding experiments, the amounts of the specific recombinant proteins was determined by 
SDS-PAGE followed by Coomassie staining and integration of the intensity of the relevant bands, using 
known amounts of bovine serum albumin as standards.
Protein-protein interaction determination by pull-down. Aliquots of glutathione agarose beads 
containing ~6 μ g of bound GST-Ppz1Cter were incubated with increasing amounts of full length Hal3, pre-
pared by digestion of recombinant GST-Hal3 with PreScission protease, for 1 h at 24 °C. The beads were 
recovered by centrifugation at 750 × g for 5 min at 4 °C and subsequently washed 3 times with 200 μ L of 
washing buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 2 mM DTT, 0.5 mM PMSF and 
protease inhibitor cocktail (Roche). Finally, the beads were resuspended in 100 μ L of washing buffer and 
33 μ L of 4 × Laemmli buffer was added. The mixture was boiled for 5 min, centrifuged at 750 × g for 
2 min at 4 °C and the supernatant recovered for SDS-PAGE analysis.
In vitro PPCDC assays. PPCDC assays were performed as previously described, using HsCoaC as 
positive control5. This assay couples the formation of the 4′ -phosphopantetheine product to E. coli phos-
phopantetheine adenylyltransferase (EcPPAT), the next enzyme in the CoA pathway. The assay links the 
pyrophosphate released by this enzyme to the oxidation of NADH, which is followed spectrophotomet-
rically. Briefly, proteins (either individually or in mixtures, with a total concentration of 60 nM), were 
added to the individual wells of a 96-well plate, followed by initiation of the reaction by addition of 
the rest of the assay mixture (60 μ L pyrophosphate reagent (Sigma-Aldrich), 0.5 mM PPC31, 2 mM ATP, 
1 mM DTT, 10 mM MgCl2, 20 mM KCl and ~1.5 μ M 6 × His-EcPPAT32 in 50 mM Tris-HCl, pH 7.6). 
The final reaction volume was 150 μ L. The reaction progress was followed at 340 nm and 37 °C using a 
microplate-based UV spectrophotometer (Varioskan, ThermoLabsystems).
Monomer exchange experiments. Monomer exchange experiments were performed by evaluating 
the activity of 120 mM of catalytically inactive heteromers after incubation for 10 min at 37 °C, in the 
presence of excess Hal3PD or Vhs3PD.
PD size exclusion chromatography and cross-linking experiments. Size exclusion chromatog-
raphy of PD complexes was performed on an ÄKTApurifier with a Superose 12 column (Amersham), 
with 50 mM phosphate (pH 7.0), 150 mM NaCl as eluant at a flow rate of 0.4 mL/min. The column was 
calibrated with suitable protein standards in a range from 29 kDa to 700 kDa (Sigma kit). Approximately 
100 μ L of the respective proteins purified in phosphate buffers were loaded onto the column.
Cross-linking experiments were performed using disuccinimydyl suberate (DSS) (Sigma) as 
cross-linking reagent, using a method derived from previously published procedures33,34. The DSS was 
dissolved in DMSO as a 24 mM stock solution, and added to protein samples (1:100 and 1:50 v/v for 
Hal3PD and Vhs3PD respectively) in 50 μ L reaction volumes, followed by incubation at 37 °C for 15 and 
40 min for Hal3PD and Vhs3PD respectively. The cross-linking reactions were quenched by addition of 
10% of 1 M Tris-HCl, pH 8, followed by SDS-PAGE analyses using 8% gels.
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Circular dichroism (CD) studies. Several different types of studies were performed by using CD by 
using a Chirascan spectrapolarimeter (Photophysics) with protein purified using the described HT buffers.
Far-UV CD. Far-UV CD spectra were obtained between 200 and 300 nm (using 1 nm increments) to 
obtain information about the respective proteins’ secondary structures. Samples contained 0.2 mg/mL 
protein and were analysed at 25 °C using a 0.05 cm cuvette. Each spectrum represents an average of at 
least three scans, and was smoothed using the Chirascan software. The obtained raw data (ellipticity (θ ) in 
millidegrees) were converted to molar ellipticity ([θ ]) with the units of deg. cm2.dmol-1 using the equation:
( )
θ =
×
× ( )
θ
C l
[ ]
100
1
1000
where C is the concentration in M and l refers to the cuvette path length in cm. For the co-expressed 
Cab3PD-containing mixtures the protein concentration was calculated by using a molecular weight esti-
mated from the approximate ratios of the different proteins obtained as assessed by SDS-PAGE. For the 
protein mixtures the approximate ratios were Hal3PD/Cab3PD (2:1), Vhs3PD/Cab3PD (2:1) and Hal3PD/
Vhs3PD/Cab3PD (2:1:1).
Visible CD and absorbance spectra. CD spectra in the visible region were collected between 300 and 
700 nm (using 1 nm increments) to gain information about the environment of the flavin cofactor. The 
CD and absorbance of protein samples (0.5 mg/mL protein) was measured simultaneously at 25 °C using 
a 0.4 cm cuvette. Each spectrum represents the average of at least three scans, and was smoothed using 
the Chirascan software. The obtained data was converted to [θ ] as above.
Determination of protein melting curves based on protein unfolding. Protein melting curves were deter-
mined by measuring the change in the CD signal at 222 nm as a function of temperature of samples 
(0.2 mg/mL protein) contained in a 0.05 cm cuvette. Changes were measured between 35 °C and 94 °C 
using a heating rate of 2 °C/min (temperature tolerance was maintained at 0.2 °C). The raw data was 
converted to fraction of folded protein using equation 2:
θ θ
θ θ
=
( − )
( − ( ))
FractionFolded
2
t U
F U
where θ t is the ellipticity at any temperature, θ F is the ellipticity of the fully folded protein and θ U is the 
ellipticity of the fully unfolded protein20. We assumed that the initially obtained absorbance values were 
those of the fully folded protein, and that the values obtained at ~90 °C represented the CD absorbance 
of the fully unfolded protein. The first derivative data was smoothed using the standard settings of 
SigmaPlot 11 (Systat Software), and the absorbance data was normalized to have values between 0 and 
1 for ease of comparison.
Determination of protein melting curves based on flavin release. Protein melting curves were also 
obtained by studying the changes in the CD spectra of the flavin cofactor of samples (0.5 mg/mL protein 
contained in a 0.4 cm cuvette) as a function of temperature. Spectra (300–500 nm) were measured at 1 
or 2.5 °C increments (temperature tolerance was maintained at 0.2 °C), with a setting time of 30 s. The 
obtained spectra were converted to melting curves by selecting the CD values at 320 nm (where a large 
change in CD signal with temperature was observed). The obtained curves were converted to fraction 
folded protein using equation 1. The melting temperatures (Tm) were subsequently determined by fit-
ting the resulting curves simultaneously to equations 3, 4 and 5 (the Gibbs-Helmholtz equation) using 
SigmaPlot 11.0 (Systat Software):
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where lb and rb are the equations for the best linear fits to the left and right baselines of the curves 
respectively, FF refers to fraction folded, Δ G is the change in free energy of unfolding, Δ HvH is the 
van’t Hoff enthalpy, T is the temperature at any point and Δ Cp is the change in heat capacity. The fol-
lowing parameter constraints were used for the curve fit: van’t Hoff enthalpy (Δ HvH) > 0; Tm > 0 and 
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Δ Cp > 1000 J/K. This equation was chosen in preference to equations derived for homo- and heterotri-
mers20,35, due to the observation of a single transition state based on the release of the flavin cofactor.
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